The 17 references in paper M. Volkov M., I. Kayukov G., A. Smirnov V., М. Волков М., И. Каюков Г., А. Смирнов В. (2010) “ФОСФОРНО-КАЛЬЦИЕВЫЙ ОБМЕН И ЕГО РЕГУЛЯЦИЯ // PHOSPHORUS-CALCIUM METABOLISM AND ITS REGULATION” / spz:neicon:nefr:y:2010:i:1:p:91-103

1
Reilly RF. The patient with disorders of serum calcium and phosphate. In: Schrier RW (ed). Manual of nephrology. Sixth ed. Philadelphia: Lippincott Williams & Wilkins; 2005: 61-78
(check this in PDF content)
2
Ермоленко ВМ. Фосфорно-кальциевый обмен и поч­ ки. В: Тареева ИЕ, ред. Нефрология: Руководство для вра­ чей. 2-е изд., перераб. и доп., Медицина, М., 2000; 62-75
(check this in PDF content)
3
Razzaque MS, St-Arnaud R, Taguchi T, Lanske B. FGF- 23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant 2005; 20 (10): 2032-2035
(check this in PDF content)
4
Torres PU, Prie D, Beck L et al. Klotho gene, phosphocalcic metabolism, and survival in dialysis. J Ren Nutr 2009; 19 (1): 50-56
(check this in PDF content)
5
Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 2007; 20 (4): 302-308
(check this in PDF content)
6
Fiorino AS. Hypercalcemia and alkalosis due to the milk- alkali syndrome: a case report and review. Yale J Biol Med 1996; 69 (6): 517-523
(check this in PDF content)
7
Fiaschi-Taesch NM, Stewart AF. Minireview: parathyroid hormone-related protein as an intracrine factor - trafficking mechanisms and functional consequences. Endocrinology 2003; 144 (2): 407-411
(check this in PDF content)
8
Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med 1997; 103 (2): 134-145
(check this in PDF content)
9
al Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet 1997; 349 (9060): 1233-1238
(check this in PDF content)
10
Lourwood DL. The pharmacology and therapeutic utility of bisphosphonates. Pharmacotherapy 1998; 18 (4): 779-789
(check this in PDF content)
11
Reber PM, Heath H 3rd. Hypocalcemic emergencies. Med Clin North Am 1995; 79 (1): 93-106
(check this in PDF content)
12
Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 1998; 352 (9124): 306-311
(check this in PDF content)
13
Cheng SC, Young DO, Huang Y et al. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3(4): 1131-1138
(check this in PDF content)
14
Brooks MJ, Melnik G. The refeeding syndrome: an approach to understanding its complications and preventing its occurrence. Pharmacotherapy 1995; 15 (6): 713-726
(check this in PDF content)
15
Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 2003; 285 (1):E1-9
(check this in PDF content)
16
Econs MJ, Francis F. Positional cloning of the PEX gene: new insights into the pathophysiology of X-linked hypophosphatemic rickets. Am J Physiol 1997; 273 (4 Pt 2): F489-498
(check this in PDF content)
17
Bugg NC, Jones JA. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 1998; 53 (9): 895-902 Поступила в редакцию 11.06.2009 г. Принята в печать 02.03.2010 г.
(check this in PDF content)